Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
Public ClinicalTrials.gov record NCT01052480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, open-label, multicenter phase 2 trial will assess the safety, efficacy, and pharmacokinetics (PK) of anti-influenza plasma in subjects with influenza A or B. Hospitalized subjects with influenza A or B that have either a low oxygen level or a high respiratory rate will be eligible for study participation. This study will enroll adults, children and pregnant women.
Study identification
- NCT ID
- NCT01052480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2010 (Actual)
- Primary completion
- Mar 2015 (Actual)
- Completion
- Nov 2015 (Actual)
- Last update posted
- Sep 5, 2017
2010 – 2015
United States locations
- U.S. sites
- 35
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095-1752 | — |
| Naval Medical Center San Diego | San Diego | California | 92134 | — |
| Los Angeles Biomedical Research Institute, CA | Torrance | California | 90502 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Washington, DC VA Med Center | Washington D.C. | District of Columbia | 20422 | — |
| University of Florida | Gainesville | Florida | 32608 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Northwestern University (NU) | Chicago | Illinois | 60611 | — |
| The Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Maryland School of Medicine Center for Vaccine Development | Baltimore | Maryland | 21201 | — |
| John Hopkins University (JHU) | Baltimore | Maryland | 21218 | — |
| Walter Reed National Military Medical Center (WRNMMC) | Bethesda | Maryland | 20889 | — |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital/Harvard Medical School | Boston | Massachusetts | 02115 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Boston Med Center | Boston | Massachusetts | 02118 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Bronson Healthcare Group | Kalamazoo | Michigan | 49007 | — |
| Saint Mary's Hospital (Mayo Clinic) | Rochester | Minnesota | 55905 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College | New York | New York | 10065 | — |
| Montefiore Medical Center/Albert Einstein College of Medicine | New York | New York | 10467 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45267-0405 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center (UPMC) | Pittsburgh | Pennsylvania | 15213 | — |
| Texas Tech University Health Science Center (HSC)- Amarillo | Amarillo | Texas | 79106 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| Texas Tech HSC-Lubbock, TX | Lubbock | Texas | 79430 | — |
| Naval Medical Center Portsmouth | Portsmouth | Virginia | 23708 | — |
| Madigan Army Medical Center (MAMC) | Tacoma | Washington | 98431 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01052480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01052480 live on ClinicalTrials.gov.